Cohen Milstein is a Washington DC-based practice with ‘a wonderful reputation of handling the most complex class action cases in the country.’ The antitrust team represents clients in cases against major names in the banking, pharmaceutical, meat, and real estate industries, often resulting in government investigations. Benjamin Brown and Brent Johnson co-chair the team, both taking leading roles in multiple valuable antitrust and wage suppression cases. The practice is complemented by Sharon Robertson, who lends her expertise in pharmaceutical lawsuits and pay-for-delay disputes. Michael Eisenkraft focuses on manipulation and collusion in the financial markets. Emmy Levens ’is a sparkling example of what every trial lawyer should endeavor to be’ and has provided invaluable protection to consumer classes. Daniel Silverman is a key name, with significant prowess in witness work, class certification, and substantiating damages. Former co-chair Richard Koffman continues to be active in cases alleging conspiratorial behavior in the telecoms and veterinary industries.
Testimonials
Collated independently by Legal 500 research team.
‘The team has exceptional depth of experience when it comes to prosecuting and managing antitrust class actions. They know how to get cases certified and are able to take the cases to trial, if necessary.'
'They know which experts to hire to help get cases certified as class actions. They also have substantive knowledge of the antitrust laws, which allows them to anticipate arguments that the defendants will make and respond accordingly.'
Work highlights
- Secured a historic settlement of $499 million in cash along with injunctive relief with defendants Morgan Stanley, Goldman Sachs, UBS, JP Morgan, and EquiLend in this ground-breaking anticompetitive class action in which plaintiffs allege these banks engaged in a group boycott.
- Secured final approval of a $485 million global settlement to resolve claims against Ranbaxy in this MDL for allegedly manipulating the FDA’s generic drug approval process to block competitors from coming to market and forcing purchasers to pay supra-competitive prices for three products.